A
Anulex
Anulex Technologies develops technologies and surgical techniques to improve the treatment of herniated discs
About Anulex
Anulex Technologies was a medical device company that developed and commercialized products for soft tissue repair, with a primary focus on treatments for the spine. The company's main product was the Xclose Tissue Repair System, a medical device designed to close the hole in the anulus fibrosus (the outer ring of the intervertebral disc) after a discectomy, a surgical procedure to remove a herniated disc.
The primary clients for Anulex's products were surgeons, specifically those performing spinal surgeries. The company operated in the medical device market, a sector that is characterized by long product development cycles, stringent regulatory requirements, and the need for extensive clinical data to support product adoption.
Anulex's business model was based on the development and sale of its proprietary medical devices to hospitals and surgical centers. The company's revenue was generated from the sales of the Xclose system. The company was privately held and raised capital from investors to fund its research and development, clinical trials, and commercialization efforts.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2001
- Headquarters
- Minnetonka, United States
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Sector
- Biotechnology
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Jun 2010 | $18M | $73M | Delphi Ventures · NEA · MB Venture Partners · Affinity Capital Management | — |
| DEBTDebt | Mar 2010 | $3.8M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Anulex is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 KaexKAEX basic - recharge overnight + protect the next day |
Zurich, Switzerland | Operational | 29 | $31M | $35M |
 Infinite Recovery HoldingsAddiction rehabilitation center based austin, texas |
Austin, United States | Operational | |||
 ENU NutritionAnd commercializes nutritional products |
Philadelphia, United States | Operational | |||
 GroupsGroups helps people recover from opiate use through therapy and medication |
Burlington, United States | Operational | |||
 O4cpO4CP - Only For Children Pharmaceuticals - Innovating For Child Care |
Paris, France | Operational | |||
 MedMark ServicesHome | Opioid Addiction | Addiction Treatment| MedMark |
Lewisville, United States | Operational | |||
 Vanda PharmaceuticalsPharmaceutical therapies for central nervous system disorders |
Washington DC, United States | Acquired | |||
 CrossTxCare coordination and referral management platform designed to streamline communication and workflows across healthcare providers |
Bozeman, United States | Acquired |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
MB Venture Partners
Affinity Capital Management
Split Rock Partners
SightLine Partners
Delphi Ventures
NEA
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Anulex on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anulex’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.